| Fondaparinux | Enoxaparin | P value |
---|---|---|---|
n = 144 | n = 144 | ||
Gender, male/female | 20/124 | 23/121 | 0.620 |
Age, years | Â | Â | Â |
  Mean ± SD | 67.3 ± 10.0 | 68.0 ± 8.8 | 0.707 |
  Range | 40-87 | 44-86 |  |
Body mass index, kg/m2 | Â | Â | Â |
  Mean ± SD | 23.4 ± 3.8 | 23.8 ± 3.6 | 0.386 |
History of venous thrombosis, n (%) | - | - | Â |
malignant tumor | 5 (3.5%) | 0 | 0.030 |
Comorbidities, n (%) | Â | Â | Â |
  Hypertension | 59 (41.0%) | 54 (37.5%) | 0.546 |
  Ischemic heart disease | 7 (4.9%) | 6 (4.2%) | 0.777 |
  Diabetes | 11 (7.6%) | 10 (6.9%) | 0.821 |
  Cerebrovascular disease | 4 (2.8%) | 3 (2.1%) | 0.702 |
Operation time, minutes | Â | Â | Â |
  Mean ± SD | 124.6 ± 38.7 | 125.6 ± 47.3 | 0.931 |
Primary diseases, n (%) | Â | Â | Â |
  Rheumatoid arthritis | 9 (6.3%) | 5 (3.5%) | 0.273 |
  Osteoarthritis | 129 (89.6%) | 129 (89.6%) | 1.000 |
  Others | 6 (4.2%) | 10 (6.9%) | 0.303 |
General anesthesia | 141 (97.9%) | 141 (97.9%) | 1.000 |
Use of elastic stocking, n (%) | 131 (91.0%) | 133 (92.4%) | 0.670 |
Use of foot pump, n (%) | 138 (95.8%) | 137 (95.1%) | 0.777 |
Use of cement, n (%) | 23 (16.0%) | 24 (16.7%) | 0.873 |
e-GFR, mL/min per 1.73Â m2 | Â | Â | Â |
  Mean ± SD | 81.9 ± 20.0 | 78.6 ± 16.8 | 0.220 |
  Range | 29.0-139.0 | 37.7-128.9 |  |
Serum albumin, g/dL | Â | Â | Â |
  Mean ± SD | 4.0 ± 0.5 | 4.1 ± 0.4 | 0.001 |
  Range | 2.4-5.0 | 2.6-5.1 |  |
Platelet count, 104/μL |  |  |  |
  Mean ± SD | 27.7 ± 7.6 | 26.0 ± 7.7 | 0.048 |